DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT00077077 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: DJ-927
DRUG: capecitabine

Sponsor

Daiichi Sankyo